These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
113 related articles for article (PubMed ID: 2391447)
1. Immunogold labeling of the low-affinity (55 kd) IL2 receptor on the surface of IL2 receptor-bearing cultured cells and mitogen-activated peripheral blood lymphocytes. McGroarty RJ; Mills GB; de Harven E J Leukoc Biol; 1990 Sep; 48(3):213-9. PubMed ID: 2391447 [TBL] [Abstract][Full Text] [Related]
2. Soluble interleukin 2 receptor release, interleukin 2 production, and interleukin 2 receptor expression in activated T-lymphocytes in vitro. Lai KN; Leung JC; Lai FM Pathology; 1991 Jul; 23(3):224-8. PubMed ID: 1838146 [TBL] [Abstract][Full Text] [Related]
3. T-cells infiltrating renal cell carcinoma display a poor proliferative response even though they can produce interleukin 2 and express interleukin 2 receptors. Alexander JP; Kudoh S; Melsop KA; Hamilton TA; Edinger MG; Tubbs RR; Sica D; Tuason L; Klein E; Bukowski RM Cancer Res; 1993 Mar; 53(6):1380-7. PubMed ID: 8443817 [TBL] [Abstract][Full Text] [Related]
4. Role of interleukin 2 receptor beta chain in initiating anti-CD3 and interleukin 2-induced proliferation of human resting T cells. Moiré N; Calvo CF; Métivier D; Perrot JY; Vaquero C; Hatakeyama M; Senik A Eur J Immunol; 1990 Sep; 20(9):1981-7. PubMed ID: 2145171 [TBL] [Abstract][Full Text] [Related]
5. The mouse high affinity IL 2 receptor complex. I. Evidence for a third molecule, the putative gamma-chain, associated with the alpha- and/or beta-chain of the receptor. Herrmann T; Diamantstein T Immunobiology; 1987 Sep; 175(3):145-58. PubMed ID: 3119468 [TBL] [Abstract][Full Text] [Related]
6. Interleukin 2-induced tyrosine phosphorylation. Interleukin 2 receptor beta is tyrosine phosphorylated. Mills GB; May C; McGill M; Fung M; Baker M; Sutherland R; Greene WC J Biol Chem; 1990 Feb; 265(6):3561-7. PubMed ID: 2303462 [TBL] [Abstract][Full Text] [Related]
7. Both the alpha and beta chains of high-affinity interleukin 2 receptors are located in intracellular vesicles when their ligand is endocytosed. Ferrer M; Hémar A; Duprez V; Hellio R; Dautry-Varsat A Eur J Cell Biol; 1993 Apr; 60(2):276-82. PubMed ID: 8330625 [TBL] [Abstract][Full Text] [Related]
8. Cyclosporine inhibits the expression of receptors for interleukin 2 and transferrin on mitogen-activated human T lymphocytes. Prince HE; John JK Immunol Invest; 1986 Aug; 15(5):463-72. PubMed ID: 3096881 [TBL] [Abstract][Full Text] [Related]
9. How interleukin-2 can affect human fibroblasts behaviour. Plaisance S; Alileche A; Han D; Rubinstein E; Sahraoui Y; Jasmin C; Azzarone B Pathol Res Pract; 1994 Oct; 190(9-10):942-9. PubMed ID: 7899144 [TBL] [Abstract][Full Text] [Related]
10. Parameters of interaction of a novel monoclonal antibody (33B3.1) with the human IL2-receptors: interrelationship between 33B3.1, anti-Tac, and IL2 binding sites. Le Mauff B; Gascan H; Olive D; Moreau JF; Mawas C; Soulillou JP; Jacques Y Hum Immunol; 1987 May; 19(1):53-68. PubMed ID: 3034838 [TBL] [Abstract][Full Text] [Related]
11. Impaired expression of interleukin-2 receptor (IL2R) in the immunosuppressed burned patient: reversal by exogenous IL2. Teodorczyk-Injeyan JA; Sparkes BG; Mills GB; Falk RE; Peters WJ J Trauma; 1987 Feb; 27(2):180-7. PubMed ID: 3102753 [TBL] [Abstract][Full Text] [Related]
12. Soluble interleukin 2 receptors released from mitogen stimulated human peripheral blood lymphocytes bind interleukin 2 and inhibit IL2 dependent cell proliferation. Chopra RK; Powers DC; Kendig NE; Adler WH; Nagel JE Immunol Invest; 1989 Oct; 18(8):961-73. PubMed ID: 2583751 [TBL] [Abstract][Full Text] [Related]
13. Sequential expression of protooncogenes during lectin-stimulated mitogenesis of normal human lymphocytes. Reed JC; Alpers JD; Nowell PC; Hoover RG Proc Natl Acad Sci U S A; 1986 Jun; 83(11):3982-6. PubMed ID: 3012540 [TBL] [Abstract][Full Text] [Related]
14. Mechanisms by which accessory cells contribute in growth of resting T lymphocytes initiated by OKT3 antibody. Palacios R Eur J Immunol; 1985 Jul; 15(7):645-51. PubMed ID: 3924633 [TBL] [Abstract][Full Text] [Related]
15. Interleukin 2 (IL 2) up-regulates its own receptor on a subset of human unprimed peripheral blood lymphocytes and triggers their proliferation. Harel-Bellan A; Bertoglio J; Quillet A; Marchiol C; Wakasugi H; Mishall Z; Fradelizi D J Immunol; 1986 Apr; 136(7):2463-9. PubMed ID: 3005412 [TBL] [Abstract][Full Text] [Related]
16. Decreased proliferation, interleukin 2 synthesis, and interleukin 2 receptor expression are accompanied by decreased mRNA expression in phytohemagglutinin-stimulated cells from elderly donors. Nagel JE; Chopra RK; Chrest FJ; McCoy MT; Schneider EL; Holbrook NJ; Adler WH J Clin Invest; 1988 Apr; 81(4):1096-102. PubMed ID: 3127423 [TBL] [Abstract][Full Text] [Related]
17. A study on OX39, a murine anti-rat interleukin 2 receptor antibody. A report on receptor binding and effects on allograft survival. Jacques Y; Paineau J; Chevalier S; Le Mauff B; Soulillou JP Transpl Int; 1988 Jul; 1(2):58-63. PubMed ID: 3076381 [TBL] [Abstract][Full Text] [Related]
18. A cytokine, lymphocyte blastogenesis inhibitory factor (LBIF), arrests mitogen-stimulated T lymphocytes at early G1 phase with no influence on interleukin 2 production and interleukin 2 receptor light chain expression. Sugimura K; Ueda Y; Takeda K; Fukuda S; Tsukahara K; Habu Y; Fujiwara H; Azuma I Eur J Immunol; 1989 Aug; 19(8):1357-64. PubMed ID: 2673797 [TBL] [Abstract][Full Text] [Related]